Reaction
Non-Hodgkin'S Lymphoma reporting signals
As of the last recalculation, Non-Hodgkin'S Lymphoma appears in 1,313 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is ROMIPLOSTIM (PRR 25.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Romiplostim | 24 | 25.7 | 25.8 |
| Bleomycin Sulfate | 16 | 24.8 | 24.9 |
| Anti-Thymocyte Globulin (Rabbit) | 11 | 21.8 | 21.8 |
| Lopinavir And Ritonavir | 17 | 20.1 | 20.2 |
| Nevirapine | 11 | 19.5 | 19.5 |
| Quinine | 10 | 18.6 | 18.6 |
| Bendamustine Hydrochloride | 13 | 17.4 | 17.4 |
| Lamivudine Oral | 26 | 16.6 | 16.6 |
| Infliximab | 188 | 15.8 | 15.8 |
| Lamivudine | 30 | 15.7 | 15.7 |
| Zidovudine | 12 | 14.3 | 14.4 |
| Mesna Injection | 6 | 11.6 | 11.6 |
| Abacavir Sulfate | 7 | 11.4 | 11.5 |
| Efavirenz | 8 | 11.4 | 11.4 |
| Mesna | 6 | 11.3 | 11.4 |
| Mercaptopurine | 12 | 11.1 | 11.1 |
| Vincristine Sulfate | 19 | 10.4 | 10.4 |
| Micafungin Sodium | 5 | 9.4 | 9.4 |
| Fludarabine Phosphate | 22 | 9.0 | 9.0 |
| Raltegravir | 9 | 8.7 | 8.7 |
| Etoposide | 39 | 8.6 | 8.6 |
| Imatinib Mesylate | 13 | 7.5 | 7.5 |
| Bendamustine Hcl | 7 | 7.2 | 7.2 |
| Ifosfamide | 9 | 6.7 | 6.7 |
| Deferasirox | 10 | 6.0 | 6.0 |
| Clozapine | 41 | 5.3 | 5.3 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 7 | 4.7 | 4.7 |